MENINGIOMA

This study tested a special type of radiation therapy called boron neutron capture therapy (BNCT) for people whose meningioma (a brain tumor) came back after prior treatment. Ten adults aged 20 and older received an injection of a boron compound (B10 L-BPA) followed by neutron be…

This study tested whether using a much lower dose of gadolinium contrast in MRI scans can still accurately detect meningiomas, a common type of brain tumor. Over 500 adults undergoing routine screening or follow-up for meningiomas received both a standard full-dose MRI and a new …

This study tested a drug called Gleolan in 108 adults with meningioma (a type of brain tumor). The drug makes tumor cells glow under a special light during surgery, helping surgeons see and remove more of the tumor. The goal was to see if Gleolan could accurately identify tumor t…

This study tested a new MRI contrast agent called RVP-001 in 18 adults with brain lesions from conditions like tumors or multiple sclerosis. The goal was to see if it is safe and effective at highlighting these lesions without using gadolinium, a metal that can build up in the bo…

This study looked at whether a type of talk therapy called cognitive behavioral therapy for insomnia (CBT-I) can help people with brain tumors who have trouble sleeping. The study included 70 adults with various brain tumors who also had insomnia. The goal was to see if the thera…

This study tested whether analyzing the genetic makeup of a child's tumor could help doctors choose better treatments. 186 children with cancers that had come back or were not responding to standard therapy took part. The goal was to see if this approach was practical and safe, n…

This study analyzed tumor and blood samples from 84 patients with brain cancer, meningioma, or sarcoma to find biomarkers that predict how well proton beam therapy works. The goal is to identify genetic or immune markers linked to tumor shrinkage six months after treatment. This …